1. Home
  2. POAI vs GXAI Comparison

POAI vs GXAI Comparison

Compare POAI & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • GXAI
  • Stock Information
  • Founded
  • POAI 2002
  • GXAI 2021
  • Country
  • POAI United States
  • GXAI United States
  • Employees
  • POAI N/A
  • GXAI N/A
  • Industry
  • POAI Industrial Specialties
  • GXAI
  • Sector
  • POAI Health Care
  • GXAI
  • Exchange
  • POAI Nasdaq
  • GXAI Nasdaq
  • Market Cap
  • POAI 9.7M
  • GXAI 7.5M
  • IPO Year
  • POAI N/A
  • GXAI 2023
  • Fundamental
  • Price
  • POAI $1.46
  • GXAI $1.47
  • Analyst Decision
  • POAI Hold
  • GXAI
  • Analyst Count
  • POAI 1
  • GXAI 0
  • Target Price
  • POAI N/A
  • GXAI N/A
  • AVG Volume (30 Days)
  • POAI 2.8M
  • GXAI 502.4K
  • Earning Date
  • POAI 03-27-2025
  • GXAI 03-26-2025
  • Dividend Yield
  • POAI N/A
  • GXAI N/A
  • EPS Growth
  • POAI N/A
  • GXAI N/A
  • EPS
  • POAI N/A
  • GXAI N/A
  • Revenue
  • POAI $1,484,223.00
  • GXAI $2,979.00
  • Revenue This Year
  • POAI N/A
  • GXAI N/A
  • Revenue Next Year
  • POAI $569.48
  • GXAI N/A
  • P/E Ratio
  • POAI N/A
  • GXAI N/A
  • Revenue Growth
  • POAI N/A
  • GXAI N/A
  • 52 Week Low
  • POAI $0.55
  • GXAI $1.01
  • 52 Week High
  • POAI $3.76
  • GXAI $19.20
  • Technical
  • Relative Strength Index (RSI)
  • POAI 55.86
  • GXAI 39.18
  • Support Level
  • POAI $1.39
  • GXAI $1.35
  • Resistance Level
  • POAI $1.58
  • GXAI $1.66
  • Average True Range (ATR)
  • POAI 0.12
  • GXAI 0.14
  • MACD
  • POAI -0.02
  • GXAI 0.00
  • Stochastic Oscillator
  • POAI 41.94
  • GXAI 14.72

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.

Share on Social Networks: